162 related articles for article (PubMed ID: 6115202)
1. Serum thyroglobulin in thyroid cancer.
Black EG; Cassoni A; Gimlette TM; Harmer CL; Maisey MN; Oates GD; Hoffenberg R
Lancet; 1981 Aug; 2(8244):443-5. PubMed ID: 6115202
[TBL] [Abstract][Full Text] [Related]
2. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
3. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma.
Grant S; Luttrell B; Reeve T; Wiseman J; Wilmshurst E; Stiel J; Donohoe D; Cooper R; Bridgman M
Cancer; 1984 Oct; 54(8):1625-8. PubMed ID: 6478402
[TBL] [Abstract][Full Text] [Related]
5. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
6. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
[TBL] [Abstract][Full Text] [Related]
7. How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma?
Välimäki M; Lamberg BA
Acta Endocrinol (Copenh); 1985 Dec; 110(4):487-92. PubMed ID: 4090912
[TBL] [Abstract][Full Text] [Related]
8. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
Ozata M; Suzuki S; Miyamoto T; Liu RT; Fierro-Renoy F; DeGroot LJ
J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
[TBL] [Abstract][Full Text] [Related]
9. Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma.
Black EG; Sheppard MC; Hoffenberg R
Clin Endocrinol (Oxf); 1987 Jul; 27(1):115-20. PubMed ID: 3652482
[TBL] [Abstract][Full Text] [Related]
10. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
12. Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases.
Druetta L; Bornet H; Sassolas G; Rousset B
Eur J Endocrinol; 1999 May; 140(5):457-67. PubMed ID: 10229914
[TBL] [Abstract][Full Text] [Related]
13. Serum thyroglobulin measurements in thyroid cancer: evaluation of 'false' positive results.
Black EG; Sheppard MC
Clin Endocrinol (Oxf); 1991 Dec; 35(6):519-20. PubMed ID: 1769134
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
Ng DC; Sundram FX; Sin AE
J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
[TBL] [Abstract][Full Text] [Related]
15. High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients?
Trimboli P; La Torre D; Ceriani L; Condorelli E; Laurenti O; Romanelli F; Ventura C; Signore A; Valabrega S; Giovanella L
Horm Metab Res; 2013 Sep; 45(9):664-8. PubMed ID: 23720229
[TBL] [Abstract][Full Text] [Related]
16. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
Rosário PW; Borges MA; Fagundes TA; Franco AC; Purisch S
Clin Endocrinol (Oxf); 2005 Feb; 62(2):121-5. PubMed ID: 15670185
[TBL] [Abstract][Full Text] [Related]
17. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of autoantibodies to thyroglobulin, thyroxine, or triiodothyronine and relationship of autoantibodies and serum concentrations of iodothyronines in dogs.
Thacker EL; Refsal KR; Bull RW
Am J Vet Res; 1992 Apr; 53(4):449-53. PubMed ID: 1586011
[TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation.
Nascimento C; Borget I; Troalen F; Al Ghuzlan A; Deandreis D; Hartl D; Lumbroso J; Chougnet CN; Baudin E; Schlumberger M; Leboulleux S
Eur J Endocrinol; 2013 Nov; 169(5):689-93. PubMed ID: 23939918
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
